CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1

Volume: 21, Issue: 1
Published: Nov 7, 2021
Abstract
Acute myeloid leukemia (AML) is a myeloid neoplasm accounts for 7.6% of hematopoietic malignancies. AML is a complex disease, and understanding its pathophysiology is contributing to the improvement in the treatment and prognosis of AML. In this study, we assessed the expression profile and molecular functions of CCAAT enhancer binding protein gamma (CEBPG), a gene implicated in myeloid differentiation and AML progression.shRNA mediated gene...
Paper Details
Title
CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1
Published Date
Nov 7, 2021
Volume
21
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.